9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
He, L; Jia, Y; Peng, J; Qian, Y; Sun, P; Wang, Y; Yang, Q; Yang, W; Zhang, T; Zhao, K | 1 |
Bai, J; Bi, Z; Li, H; Li, X; Ma, B; Ma, X; Ning, W; Shao, S; Wei, Y; Xie, C; Yang, C; Zhang, L; Zhang, R; Zhang, S; Zhou, H | 1 |
Jung, H; Kang, YY; Kim, JY; Lim, Y; Mok, H; Song, J; Yeo, WS | 1 |
3 other study(ies) available for 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Disease Models, Animal
Article | Year |
---|---|
Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Disease Models, Animal; Furocoumarins; Interleukin-1beta; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha | 2020 |
Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice.
Topics: Animals; Apoptosis; Biopsy; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Furocoumarins; Hepatic Stellate Cells; Hepatocytes; Liver Cirrhosis; Male; Mice; Protective Agents; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta | 2020 |
Byakangelicin as a modulator for improved distribution and bioactivity of natural compounds and synthetic drugs in the brain.
Topics: Administration, Intravenous; Animals; Brain; Curcumin; Disease Models, Animal; Doxorubicin; Female; Furocoumarins; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Neurogenic Inflammation; Umbelliferones | 2019 |